Abstract:The Ca(v)1.2 L-type calcium channel is a key conduit for Ca2+ influx to initiate excitation-contraction coupling for contraction of the heart and vasoconstriction of the arteries and for altering membrane excitability in neurons. Its alpha(1c) pore-forming subunit is known to undergo extensive alternative splicing to produce many Ca(v)1.2 isoforms that differ in their electrophysiological and pharmacological properties. Here, we examined the structure-function relationship of human Ca(v)1.2 with respect to the inclusion or exclusion of mutually exclusive exons of the N-terminus exons 1/1 a and IS6 segment exons 8/8a. These exons showed tissue selectivity in their expression patterns: heart variant 1a/8a, one smooth-muscle variant 1/8, and a brain isoform 1/8a. Overall, the 1/8a, when coexpressed with Ca-v beta(2a), displayed a significant and distinct shift in voltage-dependent activation and inactivation and inactivation kinetics as compared to the other three splice variants. Further analysis showed a clear additive effect of the hyperpolarization shift in V-1/2inact of Ca(v)1 .2 channels containing exon 1 in combination with 8a. However, this additive effect was less distinct for V-1/2act. However, the measured effects were beta-subunit-dependent when comparing Ca-v beta(2a) with Ca-v beta 3 coexpression. Notably, calcium-dependent inactivation mediated by local Ca2+-sensing via the N-lobe of calmodulin was significantly enhanced in exon-1-containing Ca(v)1.2 as compared to exon-1 a-containing Ca(v)1.2 channels. At the cellular level, the current densities of the 1/8a or 1/8 variants were significantly larger than the 1a/8a and 1a/8 variants when coexpressed either with Ca-v beta(2a) or Ca-v beta(3) subunit. This finding correlated well with a higher channel surface expression for the exon 1-Ca(v)1.2 isoform that we quantified by protein surface-expression levels or by gating currents. Our data also provided a deeper molecular understanding of the altered biophysical properties of alternatively spliced human Ca(v)1.2 channels by directly comparing unitary single-channel events with macroscopic whole-cell currents.

Molecular Regions Determining The Voltage-dependence of Inactivation for T-type Calcium Channel Ca(v)3.1

Structural mechanism of voltage-gated sodium channel slow inactivation.

Effects of Calcium-Binding Sites in the S2–S3 Loop on Human and Nematostella Vectensis TRPM2 Channel Gating Processes

Structural Insights into KChIP4a Modulation of Kv4.3 Inactivation

A-Type Kv4 Channel Closed-State Inactivation is Modulated by the Tetramerization Domain Interacting with Auxilary KChIP4a

The Tetramerization Domain Potentiates Kv4 Channel Function by Suppressing Closed-State Inactivation.

Molecular insights into the gating mechanisms of voltage-gated calcium channel CaV2.3

The Role of 14-3-3 Dimerization in Its Modulation of the CaV2.2 Channel

The role of 14-3-3 dimerization in its modulation of the CaV2.2 channel.

Molecular Mechanism for Divergent Regulation of Cav1.2 Ca2+ Channels by Calmodulin and Ca2+-binding Protein-1

Closed-state inactivation and pore-blocker modulation mechanisms of human CaV2.2

Computational Modeling Of Sodium Channel Inactivation

Structure, gating, and pharmacology of human Ca V 3.3 channel

Alternative Splicing at N Terminus and Domain I Modulates Ca(v)1.2 Inactivation and Surface Expression

Structural determinants of voltage-gating properties in calcium channels

Role of the CaV1.2 distal carboxy terminus in the regulation of L-type current

Homology Modeling Identifies C-Terminal Residues That Contribute to the Ca2+ Sensitivity of A Bkca Channel

Regulation and drug modulation of a voltage-gated sodium channel: Pivotal role of the S4–S5 linker in activation and slow inactivation

Functional Characterization of Alternative Splicing in the C Terminus of L-type CaV1.3 Channels.

Modulation of Inactivation Properties of CaV2.2 Channels by 14-3-3 Proteins